26th International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2025
Show local (UTC) times
10:30
Welcome Coffee
11:00
Opening Session | Day 1
11:00
Workshop Opening
Kimberly Scarsi
11:10
North-South Collaborations in Clinical Pharmacology Research
Tom Jacobs
11:30
Q&A | Opening Session Day 1
11:35
Session 1: (Re) Emerging Infections & Pandemics
11:35
Session Chairs:
Andrew Owen
Tom Fletcher
11:35
Protease Inhibitor for Pandemic Preparedness
Annette von Delft
11:55
Oral Abstract Presentation #1
Oral Abstract Presenter
12:05
Oral Abstract Presentation #2
Oral Abstract Presenter
12:15
Q&A | Session 1
12:30
Lunch | Day 1
13:40
Session 2: Post-Exposure Prophylaxis (PEP)
13:40
Session Chairs:
Melanie Nicol
Julie B. Dumond
13:30
QSP (Quantitative Systems Pharmacology) for HIV PEP
Max von Kleist
13:50
HIV PEP in Clinical Practice: Guidelines and Real-World Complexities
Steve Taylor
14:10
Q&A | Session 2
14:25
Session 3: Key Populations
14:25
Session Chairs:
Kristina Brooks
Angela Colbers
14:25
New Models for Pregnancy
Adeniyi Olagunju
14:45
Hormonal Effects on Drug Metabolism and Transporters
Lauren R. Cirrincione
15:15
Oral Abstract Presentation #3
Oral Abstract Presenter
15:25
Oral Abstract Presentation #4
Oral Abstract Presenter
15:35
Oral Abstract Presentation #5
Oral Abstract Presenter
15:45
Q&A | Session 3
15:55
PM Coffee Break | Day 1
16:50
Session 4: CMV Session
16:50
Session Chairs:
Nancy Sheehan
Minh Patrick Le
16:25
Ganciclovir PK/PD in Cytomegalovirus Therapy – Who Will Benefit from Dose Optimization?
Anne-Grete Märtson
16:45
Current and Future Treatments in Cytomegalovirus - Maribavir, Letermovir, Vaccines, mABs (Clinical Focus)
Per Ljungman
17:05
Oral Abstract Presentation #6
Oral Abstract Presenter
17:15
Oral Abstract Presentation #7
Oral Abstract Presenter
17:25
Q&A | Session 4
17:40
Networking Reception